Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Tutt

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Immunological Methods|February 27, 2001
CD40 ligation for immunotherapy of solid tumoursS M Todryk, A L Tutt, M H Green, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Initial experience in treating human lymphoma with a combination of bispecific antibody and saporinM A Bonardi, A Bell, R R French, et al.
Scandinavian Journal of Rheumatology|November 28, 2000
Rheumatoid arthritis T cells produce Th1 cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD28W M Wong, S A Vakis, K R Ayre, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectorsA L Tutt, R R French, T M Illidge, et al.
Cancer Research|July 29, 1998
Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cellsD Würflein, M Dechant, B Stockmeyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapyB Stockmeyer, M Dechant, M van Egmond, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodiesI A Heijnen, L J Rijks, A Schiel, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Immunological Methods|February 27, 2001
CD40 ligation for immunotherapy of solid tumoursS M Todryk, A L Tutt, M H Green, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Initial experience in treating human lymphoma with a combination of bispecific antibody and saporinM A Bonardi, A Bell, R R French, et al.
Scandinavian Journal of Rheumatology|November 28, 2000
Rheumatoid arthritis T cells produce Th1 cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD28W M Wong, S A Vakis, K R Ayre, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectorsA L Tutt, R R French, T M Illidge, et al.
Cancer Research|July 29, 1998
Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cellsD Würflein, M Dechant, B Stockmeyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapyB Stockmeyer, M Dechant, M van Egmond, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodiesI A Heijnen, L J Rijks, A Schiel, et al.
Pageof 3